Non-small Cell Lung Cancer Study US75 (Z-PACT)

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis Pharmaceuticals
• Treatments: Carboplatin; Docetaxel; Zoledronic Acid

Criteria

Inclusion Criteria:

• Male or Female patients at least of 18 years old

• Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery

• Women must not be pregnant or attempting to become pregnant

• Able and willing to sign informed consent

Exclusion Criteria:

• Patients with cancer that has spread to the bone

• Patients with cancer that has spread to the brain who are receiving treatment

• Patients with kidney disease

• Patients treated with other investigational drugs